Biliary Flashcards
Most common cause benign biliary stricture
Previous surgery
Cholangitis s/p liver txp, dx and tx
Anastomotic biliary stricture, ERCP stent
Meperidine metabolism and toxic metabolite
Renal, normeperidine
Asymptomatic GB polyp <1cm, tx
Surveillance US yearly
Asymptomatic GB polyp >1cm, tx
Lap chole
Asymptomatic GB polyp >2cm, tx
Cancer workup prior to sx
GB ca limited to laminate propria, tx
T1a, Simple cholecystectomy
GB ca invading muscle or perimuscular connective tissue, tx
T1b/T2, chole with en bloc IVb/V resection and portal/hepatoduodenal lig lymphadenectomy
GB ca invading visceral peritoneum/adjacent liver or 2+ adjacent organs, tx
T3 and T4, consider extended right hepatectomy
Risk factors cholangiocarcinoma
PSC, choledochal cysts, UC, bil tract infxns
Absolute contraindications to lap chole
Uncorrected coagulopathy, inability to tolerate pneumo
Recent trauma, tachy with blood from ampulla of Vater, dx and tx
Hemobilia, angioembolization
Black gallstones, dx
Sickle cell or hereditary spherocytosis
Several small gallbladder polyps with cholesterol laden macrophages, dx
Cholesterolosis
Fever, jaundice, abd pain, dx and tx
Acute cholangitis, fluids, IV abx and ERCP for decompression
Aberrant duct during lap chole, next step
IOC
Future liver remnant volume
20% healthy, 30% liver dysfunction, 40% cirrhosis
Gold standard test to determine Future Liver Remnant
CT Volumetry
Gold standard tx for inadequate future liver remanant
Portal vein embolization
Absolute contraindication portal vein embolization
Portal hypertension
Painless jaundice, elevated C19-9, CBD stricture; dx
Lower duct cholangiocarcinoma
IOC without contrast in duo; next step
1.0mg glucagon
Gallbladder Ca first metastasis
Cystic duct lymph nodes
Nonop management of gallstones
Ursodeoxycholic acid